Flash 7 is required to view this content. Download Flash 7.
Advancing Life Science Together ®
As scientists and engineers pioneering new cures to mankind's most challenging health issues, you rely on Millipore as a trusted partner who for more than 50 years has supported you with a continuum of cutting edge tools, technologies and application solutions to ensure success in your research, development and production.

Specialty Markets
Diagnostics & OEM, Vaccines, Beverage, Drinking Water and Wastewater, Hospital Pharmacy, and Microelectronics.
Media Room

Millipore Delivers Outstanding 2009 Financial Results
Millipore revenues for the fourth quarter grew 7 percent from the previous year, totaling $426.0 million. Excluding a 5 percent benefit from changes in foreign currency, Millipore generated organic revenue growth of 2 percent. The Company’s fourth quarter revenue growth was adversely affected by six fewer days in the quarter compared to the fourth quarter of 2008. On a divisional basis, excluding changes in foreign currency, Millipore’s Bioprocess Division generated organic revenue growth of 4 percent...

Webcast: Millipore Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Millipore will webcast a conference call to discuss its financial results, business outlook, and related corporate and financial matters...

Martin Madaus on NECN's This Week in Business
Martin Madaus appeared on NECN last Sunday, where he discussed 2009 financials, the release of the MilliPROBE® Detection System, and Millipore's continued ability to weather the recession...










